Aberrations in FGFR1–4 are found in 5–10% of human cancers, with increased frequency (10–30%) in urothelial cancer and intrahepatic cholangiocarcinoma [4]. The gene discussed is FGFR1; the disease is intrahepatic cholangiocarcinoma.